X-ray, CT Scan:

DO NOT wear the smart transmitter during medical x-rays or computed tomography (CT) scans. To avoid interference with results, remove the smart transmitter before undergoing medical x-ray or CT scans. Make sure your health care professional knows about your smart transmitter.

Eversense^® E3 Sensor is manufactured by Senseonics across the US and Europe.
Eversense^® E3 Transmitter is manufactured by Senseonics in Minnesota, USA.

Yes.
(Customer Service team – see approved talking points/script on account deletion)

In extreme temperature, the system will present a High Sensor or High Transmitter Temperature Alert. Once the condition changes back to normal operating range, the system will display glucose values again.

Transmitter:
An alert appears every 20 minutes when your smart transmitter temperature is too high.
No glucose reading is displayed until the smart transmitter temperature is within normal operating conditions.
Reduce the smart transmitter temperature by moving to a cooler environment. Once the smart transmitter temperature is below 42 °C (108 °F), it will resume displaying glucose values.
You may temporarily remove the smart transmitter to cool it down. Once the smart transmitter is back to a lower temperature, be sure to replace it over the sensor.

Sensor:
The High Sensor Temperature Alert will appear every 20 minutes when the sensor temperature is too high. No glucose reading is displayed until the sensor temperature is within normal operating conditions. Go to a cooler environment to reduce the sensor temperature. Briefly remove the smart transmitter while the sensor temperature cools to between 26 - 40° C (81 - 104 °F). Then put the smart transmitter back on to start receiving glucose values again from the sensor. When you place the smart transmitter back on the sensor site, it may take up to 10 minutes for sensor communication to re-start and for glucose readings to appear in the app.

  

The system is indicated (approved) for use to replace fingerstick blood glucose measurements for diabetes treatment decisions.
Pay close attention to your glucose values, symptoms, and trends. If your symptoms are different than the sensor glucose values or what the alert indicates, confirm your glucose value with a blood glucose meter test before making a treatment decision.*

To make a treatment decision, the user should consider:

• Status bar information.
• Current sensor glucose value – the current glucose value should be displayed in black.
• Trend arrow – a trend arrow should be displayed.
• Recent trend information and alerts.

When to NOT make a treatment decision:

• No glucose value is displayed.
• No trend arrow is displayed.
• Your symptoms do not match the glucose information displayed.
• The current sensor glucose value is displayed in grey.
• The status bar is displayed in orange.
• You are taking medications of the tetracycline class.

   

* If you have any uncertainly in how or when to make treatment decisions, always speak with your healthcare professional.

Note: Always refer to the glucose information on your Eversense CGM App on your smartphone to make treatment decisions. Do not use a secondary display like the Apple Watch or Eversense NOW.

Eversense E3 has demonstrated excellent accuracy when you need it most - we’ve demonstrated 99% of high (180 mg/dL) and 94% of low (70 mg/dL) glucose events¹ detected correctly and essentially no compression lows.²

1. Senseonics. (2023) Eversense E3 Continuous Glucose Monitoring System User Guide. LBL-6002-01-001_Rev C
2. Christiansen MP et al. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. DIABETES TECHNOLOGY & THERAPEUTICS 2018; 20(3):197-206